Pharmacological arginase inhibition prevented eNOS KO RBC-induced endothelial dysfunction (Fig. 10A) but had no impact on aortae co-incubated with WT RBC (Fig. 10C). The gene discussed is NOS3; the disease is endothelial dysfunction.